E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
<p>Abstract</p> <p>Background</p> <p>E7080 is an orally active multi-targeted kinase inhibitor whose targets include vascular endothelial growth factor receptors (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptors (PDGFR). It h...
Main Authors: | Macleod Kenneth, Patel Hitesh, Mason Susan, Glen Hilary, Brunton Valerie G |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-07-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/309 |
Similar Items
-
Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma
by: Zhao Y, et al.
Published: (2015-08-01) -
LINC02688 and PP7080 as novel biomarkers in early diagnosis of gastric cancer
by: Sadegh Fattahi, et al.
Published: (2021-06-01) -
Mutations in pmrB Confer Cross-Resistance between the LptD Inhibitor POL7080 and Colistin in Pseudomonas aeruginosa
by: Romano, Keith P., et al.
Published: (2020) -
The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
by: Diana J Uribe, et al.
Published: (2017-01-01) -
The Tyrosine Kinase Pyk2 Promotes Migration and Invasion of Glioma Cells
by: Christopher A. Lipinski, et al.
Published: (2005-05-01)